Company: CNS
Filing Date: 2025-09-15
Form Type: 8-K
Source: 0001193125-25-203653
Chunk: 0

Company: COHEN & STEERS, INC.
Filing Date: 2025-09-15
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02.      Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.  

On September 11, 2025, Raja Dakkuri provided notice to Cohen & Steers, Inc. (the “ Company”) of his decision to resign from his positions as Executive Vice President, Chief Financial Officer of the Company. Mr. Dakkuri will remain with the Company in such positions through October 17, 2025 (the “ Effective Date”) to ensure an orderly transition of responsibilities. Mr. Dakkuri has secured another opportunity, and his resignation was not the result of any disagreement with the Company or any matter related to its operations, policies, practices or financial reporting.

The Company has appointed Michael Donohue, Senior Vice President and Controller of the Company, to the position of Interim Chief Financial Officer of the Company, effective on the Effective Date. Mr. Donohue will retain his positions as Senior Vice President and Controller.

Mr. Donohue, age 50, has served as Senior Vice President and Controller of the Company since May 2023. Prior to joining the Company, he served in various positions at Hamilton Lane from 2008 until 2023, most recently as a Managing Director and Corporate Controller. Mr. Donohue’s experience also includes prior finance and accounting roles at PQ Corporation and KPMG LLP. Mr. Donohue has a BS degree in Accounting from Pennsylvania State University and an MBA degree from Villanova University.

In connection with Mr. Donohue’s appointment as Interim Chief Financial Officer, the compensation committee of the Company’s board of directors has approved a bonus award to Mr. Donohue in an aggregate amount of $300,000, consisting of (1) $150,000 in cash, payable during the first quarter of 2026, and (2) a number of Company restricted stock units equal to the quotient of $150,000 divided by the closing price of the Company’s common stock on October 17, 2025 (the “ Grant Date”), to be granted on the Grant Date and to vest ratably over four years on each annual anniversary of the Grant Date. Except as provided herein, the terms of such restricted stock units are the same as those previously disclosed by the Company and applicable to Company executive officers generally, including customary restrictive covenants relating to non-interference, non-solicitationand non-disparagement.